Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol.

Jennifer G. Robinson | Kyle J. Gaulton | Emily H Turner | Ellen M. Schmidt | C. Carlson | M. Rieder | M. Fornage | A. Hofman | A. Uitterlinden | T. Assimes | A. Reiner | D. Levy | M. McCarthy | M. Rivas | S. Gabriel | G. Abecasis | H. Kang | T. Lumley | D. Altshuler | E. Boerwinkle | D. Nickerson | C. Lindgren | L. Groop | M. Boehnke | Joshua D. Smith | V. Gudnason | P. Sætrom | Qunyuan Zhang | I. Borecki | Albert Vernon Smith | C. Kooperberg | A. Folsom | D. Lin | T. Meitinger | B. Psaty | D. Siscovick | E. Lange | J. Flannick | D. Ruderfer | C. Willer | Yun Li | S. Kathiresan | J. Rotter | I. Rudan | E. Stahl | A. Isaacs | C. V. van Duijn | L. Cupples | J. Robinson | C. O’Donnell | R. Jackson | K. North | U. Peters | R. Do | G. Peloso | James G. Wilson | C. Bizon | J. Bis | G. Jun | O. Gottesman | E. Bottinger | S. Rich | C. Hayward | W. Post | M. Feitosa | N. Franceschini | X. Sim | A. Manning | A. Correa | Q. Duan | P. Schreiner | E. Fox | G. Jarvik | C. Ballantyne | Y. E. Chen | R. Loos | O. Holmen | K. Hveem | E. Schmidt | M. Griswold | P. Auer | C. Fuchsberger | A. Locke | Yingchang Lu | L. Lange | Jacy R. Crosby | H. Taylor | R. Tracy | J. Huffman | D. Crosslin | D. Farlow | He Zhang | J. Jakobsdóttir | E. Rosenthal | Zheng-Zheng Tang | Shuo Jiao | C. Wassel | Chenyi Xue | Youna Hu | M. Tsai | Kuo-Ping Li | Ji Zhang | P. Durda | L. Martin | Deborah N. Farlow | A. Smith | K. Gaulton | Kuo- Li | Emily H. Turner | R. Jackson | A. Smith | A. Uitterlinden | Ellen M. Schmidt | A. Hofman | C. V. van Duijn | B. Psaty | R. Loos | M. McCarthy | M. McCarthy | D. Levy | A. Correa | R. Jackson

[1]  T. Dawber,et al.  The Framingham Study , 2014 .

[2]  Tanya M. Teslovich,et al.  Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.

[3]  K. Hveem,et al.  COHORT PROFILE Cohort Profile : The HUNT Study , Norway , 2013 .

[4]  M. Rieder,et al.  Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. , 2012, American journal of human genetics.

[5]  Jacob A. Tennessen,et al.  Evolution and Functional Impact of Rare Coding Variation from Deep Sequencing of Human Exomes , 2012, Science.

[6]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.

[7]  M. Cagy,et al.  Environmental factors, familial aggregation and heritability of total cholesterol, low density lipoprotein-cholesterol and high density lipoprotein-cholesterol in a Brazilian population assisted by the Family Doctor Program. , 2011, Public health.

[8]  Jonathan C. Cohen,et al.  Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. , 2010, The New England journal of medicine.

[9]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[10]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[11]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[12]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[13]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[14]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[15]  Jonathan C. Cohen,et al.  PCSK9: a convertase that coordinates LDL catabolism Published, JLR Papers in Press, November 19, 2008. , 2009, Journal of Lipid Research.

[16]  I. Rudan,et al.  Genome-wide association study of biochemical traits in Korcula Island, Croatia. , 2009, Croatian medical journal.

[17]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.

[18]  Alexander Pertsemlidis,et al.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.

[19]  S. Leal,et al.  Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. , 2008, American journal of human genetics.

[20]  R. Hegele,et al.  Monogenic pediatric dyslipidemias: classification, genetics and clinical spectrum. , 2008, Molecular genetics and metabolism.

[21]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[22]  V. Gudnason,et al.  Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. , 2007, American journal of epidemiology.

[23]  G. Abecasis,et al.  Heritability of Cardiovascular and Personality Traits in 6,148 Sardinians , 2006, PLoS genetics.

[24]  Jonathan C. Cohen,et al.  A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol. , 2006, American journal of human genetics.

[25]  Jonathan C. Cohen,et al.  Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[26]  H. Muller.  The American Journal of Human Genetics Vol . 2 No . 2 June 1950 Our Load of Mutations 1 , 2006 .

[27]  I. Fokkema,et al.  LOVD: Easy creation of a locus‐specific sequence variation database using an “LSDB‐in‐a‐box” approach , 2005, Human mutation.

[28]  Alexander Pertsemlidis,et al.  Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9 , 2005, Nature Genetics.

[29]  Daniel W. Jones,et al.  Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study. , 2005, Ethnicity & disease.

[30]  A. Hofman,et al.  Determinants of disease and disability in the elderly: The Rotterdam elderly study , 1991, European Journal of Epidemiology.

[31]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[32]  Anand K. Srivastava,et al.  Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption , 2001, Nature Genetics.

[33]  M P Epstein,et al.  Improved inference of relationship for pairs of individuals. , 2000, American journal of human genetics.

[34]  Thorsten Joachims,et al.  Making large-scale support vector machine learning practical , 1999 .

[35]  JoAnn E. Manson,et al.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. , 1998, Controlled clinical trials.

[36]  D C Rao,et al.  NHLBI Family Heart Study: objectives and design. , 1996, American journal of epidemiology.

[37]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[38]  Aric Invest.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators , 1989 .

[39]  A. Folsom,et al.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.

[40]  S B Hulley,et al.  CARDIA: study design, recruitment, and some characteristics of the examined subjects. , 1988, Journal of clinical epidemiology.

[41]  S. Young,et al.  Genetic analysis of a kindred with familial hypobetalipoproteinemia. Evidence for two separate gene defects: one associated with an abnormal apolipoprotein B species, apolipoprotein B-37; and a second associated with low plasma concentrations of apolipoprotein B-100. , 1987, The Journal of clinical investigation.

[42]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[43]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[44]  W. Kannel,et al.  Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. , 1961, Annals of internal medicine.

[45]  T. Dawber,et al.  Epidemiological approaches to heart disease: the Framingham Study. , 1951, American journal of public health and the nation's health.